Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment
Henrique J. Cardoso, Cátia V. Vaz, Tiago M. A. Carvalho, et al.
Life Sciences (2018) Vol. 218, pp. 274-283
Closed Access | Times Cited: 11

Showing 11 citing articles:

Glycolysis-induced drug resistance in tumors—A response to danger signals?
Fabrizio Marcucci, Cristiano Rumio
Neoplasia (2021) Vol. 23, Iss. 2, pp. 234-245
Open Access | Times Cited: 74
Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
Mostafa Vaghari‐Tabari, Gordon A. Ferns, Durdi Qujeq, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 8, pp. 5512-5532
Closed Access | Times Cited: 71
Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition
Tzu-Ping Lin, Pei‐Chun Chen, Ching-Yu Lin, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Expression of lactate dehydrogenase is induced during hypoxia via HIF-1 in the mud crab Scylla paramamosain
Jiawei Xie, Chang-Hong Cheng, Yu-Kun Jie, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2019) Vol. 225, pp. 108563-108563
Closed Access | Times Cited: 27
Revisiting prostate cancer metabolism: From metabolites to disease and therapy
Henrique J. Cardoso, Tiago M. A. Carvalho, Lara R. S. Fonseca, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1499-1538
Closed Access | Times Cited: 27
Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma
Özlem Çoban, Zelihagül Değim, Şükran Yılmaz, et al.
Drug Development Research (2019) Vol. 80, Iss. 5, pp. 556-565
Closed Access | Times Cited: 23
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation
Henrique J. Cardoso, Marília I. Figueira, Cátia V. Vaz, et al.
Cellular Oncology (2021) Vol. 44, Iss. 2, pp. 385-403
Closed Access | Times Cited: 19
The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
Ximing Li, Zhi Chen, Zuan Li, et al.
BMC Urology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 12
The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress
Joana Gonçalves, Mariana Feijó, Sílvia Socorro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 719-719
Open Access
Machine Learning-Based Cell Death Marker for Predicting Prognosis and Identifying Tumor Immune Microenvironment in Prostate Cancer
Feng Gao, Yasheng Huang, Mei Yang, et al.
Heliyon (2024), pp. e37554-e37554
Open Access
Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α
Md Junayed Nayeem, Aya Yamamura, Hisaki Hayashi, et al.
Life Sciences (2021) Vol. 288, pp. 120171-120171
Closed Access | Times Cited: 2
Page 1

Scroll to top